Table 2

Primary and secondary outcomes: unadjusted means and 95% CIs by study arm and time

BaselineImmediately after the intervention6 Months after the intervention12 Months after the intervention
Participants (n)Mean (95% CI)Participants (n)Mean (95% CI)Participants (n)Mean (95% CI)Participants (n)Mean (95% CI)
Primary outcome
 HbA1c (%)
  Standard DSME11110.41 (10.00, 10.83)1019.79 (9.40, 10.18)9210.14 (9.66, 10.62)9010.36 (9.87, 10.85)
  Adapted DSME11010.51 (10.06, 10.96)1079.36 (9.00, 9.71)969.89 (9.45, 10.34)839.64 (9.18, 10.10)
 HbA1c (mmol/mol)
  Standard DSME11190.3 (85.8, 94.9)10183.5 (79.2, 87.8)9287.3 (82.1, 92.6)9089.7 (84.4, 95.1)
  Adapted DSME11091.4 (86.5, 96.3)10778.8 (74.9, 82.6)9684.6 (79.8, 89.5)8381.9 (76.8, 86.9)
Secondary outcomes
 BMI (kg/m2)
  Standard DSME11031.46 (30.52, 32.41)10231.46 (30.48, 32.44)8931.31 (30.31, 32.30)9031.46 (30.43, 32.49)
  Adapted DSME10830.50 (29.37, 31.64)10530.68 (29.60, 31.78)9231.26 (30.05, 32.48)9130.84 (29.54, 32.14)
 Total cholesterol (mg/dL)
  Standard DSME111189.68 (182.47, 196.90)102181.64 (174.07, 189.20)91173.81 (165.75, 181.88)90179.42 (170.81, 188.03)
  Adapted DSME110181.23 (174.10, 188.36)106169.50 (163.30, 175.70)96177.66 (169.31, 186.01)83168.22 (160.24, 176.19)
 HDL (mg/dL)
  Standard DSME10637.81 (35.73, 39.89)9636.49 (34.65, 38.32)9036.32 (34.30, 38.34)8736.31 (34.27, 38.35)
  Adapted DSME10535.99 (34.02, 37.96)10337.01 (34.65, 39.36)9338.32 (36.01, 40.63)7936.16 (33.75, 38.58)